<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Dalsgaard | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/monthasia71/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/monthasia71/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Dalsgaard.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">77a5468e6a9773c9885dda25227e2307</guid>
				<title>Dalsgaard posted an update: Further applications of capturing the 'true' CTCs derived [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42943/</link>
				<pubDate>Sun, 09 Feb 2025 12:03:22 -0800</pubDate>

									<content:encoded><![CDATA[<p>Further applications of capturing the &#8216;true&#8217; CTCs derived from postoperative mice were successfully developed to predict tumour prognosis based on the number of captured CTCs. Finally, the prediction was verified through long-term observation of mice with excised tumours. The acoustofluidic device can efficiently capture CTCs and precisely predict&hellip;<span class="activity-read-more" id="activity-read-more-42943"><a href="http://www.nationalboardinstitute.com/activity/p/42943/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bb8b4a3e35494032a6eac79dc88d9cd6</guid>
				<title>Dalsgaard posted an update: Emergencies in outpatient clinics are rare. However, [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41909/</link>
				<pubDate>Sat, 08 Feb 2025 11:31:04 -0800</pubDate>

									<content:encoded><![CDATA[<p>Emergencies in outpatient clinics are rare. However, potentially catastrophic events can be challenging to manage due to a variety of factors, including limited equipment and staff. The purpose of this quality improvement project was to improve the staff knowledge and familiarity with critical performance elements for emergencies encountered in&hellip;<span class="activity-read-more" id="activity-read-more-41909"><a href="http://www.nationalboardinstitute.com/activity/p/41909/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3cfc7ddf5d01ca7bf5bdbd5324bb9c74</guid>
				<title>Dalsgaard posted an update: Team training interventions to improve team effectiveness [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40189/</link>
				<pubDate>Thu, 06 Feb 2025 14:14:26 -0800</pubDate>

									<content:encoded><![CDATA[<p>Team training interventions to improve team effectiveness within healthcare are widely used. However, in-depth knowledge of how healthcare professionals experience such team training curricula and their implementation processes, as well as how contextual factors impact implementation, is currently missing. The aim of this study is therefore to&hellip;<span class="activity-read-more" id="activity-read-more-40189"><a href="http://www.nationalboardinstitute.com/activity/p/40189/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2f8b5becedf6aff3ad7649e774346f98</guid>
				<title>Dalsgaard posted an update: The gastric acid exposed cells presented with high green [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38515/</link>
				<pubDate>Tue, 04 Feb 2025 11:48:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>The gastric acid exposed cells presented with high green fluorescence signals after staining with the metabolic probe CFDA-AM, which indicated intact (live) cells due to being metabolically active, whereas when the same cells were stained with the DNA probe (TO), these appeared to be in a &#8220;stressed state&#8221; due to loss of membrane integrity. Damaged&hellip;<span class="activity-read-more" id="activity-read-more-38515"><a href="http://www.nationalboardinstitute.com/activity/p/38515/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8517636e6d6c91fbcdc81ae18c43609a</guid>
				<title>Dalsgaard posted an update: QGS had 222 potential therapeutic targets associated with [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37773/</link>
				<pubDate>Mon, 03 Feb 2025 12:07:43 -0800</pubDate>

									<content:encoded><![CDATA[<p>QGS had 222 potential therapeutic targets associated with MAFLD. Enrichment analysis among these targets revealed that QGS affected biological functions/pathways such as the regulation of lipid metabolic processes (GO 0019216) and the non-alcoholic fatty liver disease pathway (hsa04932), and identified Srebp-1 as a key regulator in the synthesis&hellip;<span class="activity-read-more" id="activity-read-more-37773"><a href="http://www.nationalboardinstitute.com/activity/p/37773/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0d31799bec3272d61d7facd98f543ab4</guid>
				<title>Dalsgaard posted an update: 24, p = 0.004). This association remained at a trend-level [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36662/</link>
				<pubDate>Sun, 02 Feb 2025 11:34:19 -0800</pubDate>

									<content:encoded><![CDATA[<p>24, p = 0.004). This association remained at a trend-level after adjustment for high-risk imaging features (HR = 1.68, p = 0.10).</p>
<p> DAWM is present in a similar proportion of patients with CIS and clinically definite MS, and it is associated with increased risk of conversion to MS over 6 months.</p>
<p>DAWM is present in a similar proportion of&hellip;<span class="activity-read-more" id="activity-read-more-36662"><a href="http://www.nationalboardinstitute.com/activity/p/36662/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">00bc4379a7990b15661cfb5501e0b850</guid>
				<title>Dalsgaard posted an update: Platelet responses to rhodocytin were also affected in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35890/</link>
				<pubDate>Sat, 01 Feb 2025 11:45:10 -0800</pubDate>

									<content:encoded><![CDATA[<p>Platelet responses to rhodocytin were also affected in GpIbαΔsig/Δsig platelets but to a lesser extent than those with CRP. GpIbαΔsig/Δsig platelets formed smaller aggregates than wild-type platelets on collagen-coated microchannels at low, medium and high shear. In response to both VWF and collagen binding, flow assays performed with plasm&hellip;<span class="activity-read-more" id="activity-read-more-35890"><a href="http://www.nationalboardinstitute.com/activity/p/35890/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">383be042c793f6bb9b013521950af111</guid>
				<title>Dalsgaard posted an update: Chimeric antigen receptor T-cells (CAR T-cells) for the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30934/</link>
				<pubDate>Tue, 28 Jan 2025 15:57:08 -0800</pubDate>

									<content:encoded><![CDATA[<p>Chimeric antigen receptor T-cells (CAR T-cells) for the treatment of relapsing/refractory B-cell precursor acute lymphoblastic leukemia have led to exciting clinical results. However, CAR T-cell approaches revealed a potential risk of CD19-/CAR+ leukemic relapse due to inadvertent transduction of leukemia cells.</p>
<p> METHODS We evaluated the impact&hellip;<span class="activity-read-more" id="activity-read-more-30934"><a href="http://www.nationalboardinstitute.com/activity/p/30934/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">34a71c95502b035db04db8d403207eab</guid>
				<title>Dalsgaard became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30904/</link>
				<pubDate>Tue, 28 Jan 2025 15:54:35 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>